These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Rampias T, Boutati E, Pectasides E, Sasaki C, Kountourakis P, Weinberger P, Psyrri A. Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420 [Abstract] [Full Text] [Related]
3. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. Rampias T, Sasaki C, Weinberger P, Psyrri A. J Natl Cancer Inst; 2009 Mar 18; 101(6):412-23. PubMed ID: 19276448 [Abstract] [Full Text] [Related]
4. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas. Rietbergen MM, Snijders PJ, Beekzada D, Braakhuis BJ, Brink A, Heideman DA, Hesselink AT, Witte BI, Bloemena E, Baatenburg-De Jong RJ, Leemans CR, Brakenhoff RH. Int J Cancer; 2014 May 15; 134(10):2366-72. PubMed ID: 24249631 [Abstract] [Full Text] [Related]
8. Biomarkers of HPV in head and neck squamous cell carcinoma. Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT. Cancer Res; 2012 Oct 01; 72(19):5004-13. PubMed ID: 22991304 [Abstract] [Full Text] [Related]
9. Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options. Brown RE, Naqvi S, McGuire MF, Buryanek J, Karni RJ. J Otolaryngol Head Neck Surg; 2017 Aug 17; 46(1):52. PubMed ID: 28818106 [Abstract] [Full Text] [Related]
10. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells. Lu W, Feng L, Li P, Wang Y, Du Y, Chen X, Wu S, Zhao G, Lou W. Oncol Rep; 2016 Jan 17; 35(1):99-106. PubMed ID: 26497405 [Abstract] [Full Text] [Related]
11. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest. Li C, Johnson DE. Cell Cycle; 2013 Mar 15; 12(6):923-34. PubMed ID: 23421999 [Abstract] [Full Text] [Related]
12. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model. Callejas-Valera JL, Iglesias-Bartolome R, Amornphimoltham P, Palacios-Garcia J, Martin D, Califano JA, Molinolo AA, Gutkind JS. Carcinogenesis; 2016 Oct 15; 37(10):1014-25. PubMed ID: 27538837 [Abstract] [Full Text] [Related]
13. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB. Cancer Gene Ther; 1995 Mar 15; 2(1):19-32. PubMed ID: 7621252 [Abstract] [Full Text] [Related]
17. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system. Chen Y, Jiang H, Wang T, He D, Tian R, Cui Z, Tian X, Gao Q, Ma X, Yang J, Wu J, Tan S, Xu H, Tang X, Wang Y, Yu Z, Han H, Das BC, Severinov K, Hitzeroth II, Debata PR, Xu W, Fan W, Jin Z, Cao C, Yu M, Xie W, Huang Z, Hu Z, You Z. Antiviral Res; 2020 Jun 15; 178():104794. PubMed ID: 32298665 [Abstract] [Full Text] [Related]